3384 related articles for article (PubMed ID: 7399746)
1. The requirement for monocytes in spontaneous cytotoxicity by lymphocytes from healthy donors and melanoma patients.
de Vries JE; Mendelsohn J; Bont WS
Int J Cancer; 1980 Jan; 25(1):73-84. PubMed ID: 7399746
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediate cytotoxicity in vitro of human lymphocytes against a tissue culture melanoma cell line (igr3).
Peter HH; Pavie-Fischer J; Fridman WH; Aubert C; Cesarini JP; Roubin R; Kourilsky FM
J Immunol; 1975 Aug; 115(2):539-48. PubMed ID: 1171141
[TBL] [Abstract][Full Text] [Related]
4. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
Richter M; Kazaniwsky N
Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte cytotoxicity of patients developing multiple primary melanomas.
Mukherji B; Dayal Y
Cancer; 1980 Oct; 46(7):1566-71. PubMed ID: 6968241
[TBL] [Abstract][Full Text] [Related]
6. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients.
de Vries JE; Rümke P
Int J Cancer; 1976 Feb; 17(2):182-90. PubMed ID: 942943
[TBL] [Abstract][Full Text] [Related]
7. The influence of different isolation procedures and the use of target cells from melanoma cell lines and short-term cultures on the non-specific cytotoxic effects of lymphocytes from healthy donors.
de Vries JE; Meyering M; van Dongen A; Rümke P
Int J Cancer; 1975 Mar; 15(3):391-400. PubMed ID: 1056313
[TBL] [Abstract][Full Text] [Related]
8. Natural cytotoxicity of lymphocytes and monocytes and its augmentation by OK432 in melanoma patients.
Yanagawa E; Uchida A; Kokoschka EM; Micksche M
Cancer Immunol Immunother; 1984; 16(3):131-6. PubMed ID: 6200209
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
O'Neill PA; Mackler BF; Romsdahl MM
J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
[TBL] [Abstract][Full Text] [Related]
11. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
Nishiya K; Horwitz DA
J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
[TBL] [Abstract][Full Text] [Related]
12. Characterization by monoclonal antibodies of the cytotoxic effector cells in human peripheral blood mononuclear cells reactive against anchorage-dependent tumour cell lines.
Chang ZL; Hoffman T; Stevenson HC; Trinchieri G; Herberman RB
Scand J Immunol; 1983 Nov; 18(5):451-9. PubMed ID: 6648368
[TBL] [Abstract][Full Text] [Related]
13. The antibody-independent cytotoxic activity of normal circulating human leucocytes. II. Failure to demonstrate effector cell-target cell interaction and target cell specificity of the circulating cytotoxic-enhancing factor.
Richter M; Banerjee D; Sklar S
Immunology; 1981 Sep; 44(1):109-18. PubMed ID: 6944271
[TBL] [Abstract][Full Text] [Related]
14. The role of target cells, monocytes, and Fc receptor-bearing lymphocytes in human spontaneous cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity.
de Vries JE; Mendelsohn J; Bont WS
J Immunol; 1980 Jul; 125(1):396-405. PubMed ID: 7381206
[No Abstract] [Full Text] [Related]
15. Variables and specificity of in vitro lymphocyte-mediated cytotoxicity in human melanoma.
Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
Cancer Res; 1975 Dec; 35(12):3721-30. PubMed ID: 1192430
[TBL] [Abstract][Full Text] [Related]
16. Requirement for monocytes in the spontaneous cytotoxic effects of human lymphocytes against non-lymphoid target cells.
de Vries JE; Mendelsohn J; Bont WS
Nature; 1980 Feb; 283(5747):574-6. PubMed ID: 7354840
[TBL] [Abstract][Full Text] [Related]
17. Monocyte mediated cytotoxic activity against melanoma.
te Velde AA; Figdor CG
Melanoma Res; 1992; 1(5-6):303-9. PubMed ID: 1422187
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. II. Is the complement receptor necessarily present on the killer cells?
Pross HF; Baines MG; Jondal M
Int J Cancer; 1977 Sep; 20(3):353-8. PubMed ID: 903188
[TBL] [Abstract][Full Text] [Related]
19. Antibody dependent cellular cytotoxicity and mitogen responsiveness of human peripheral blood lymphocytes differing in avidity for sheep erythrocytes.
Jónsdóttir I; Dillner-Centerlind ML; Perlmann H; Perlmann P
Scand J Immunol; 1979; 10(6):525-33. PubMed ID: 542806
[TBL] [Abstract][Full Text] [Related]
20. Human peripheral Nullymphocytes: ultrastructural aspects of the "K" cell effect against a melanoma target cell.
Cesarini JP; Roubin R; Kalden JR; Peter HH
Biomedicine; 1978; 28(4):219-25. PubMed ID: 737273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
